JIUYUAN GENE(02566),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02566 JIUYUAN GENE

Market Closed 12-12 15:59:13

8.330

+0.330

+4.13%

High8.450	Low8.180	Vol95.60K
Open8.180	D1 Closing8.000	Amplitude3.38%
Mkt Cap2.04B	Tradable Cap907.97M	Total Shares245.00M
T/O798.06K	T/O Rate0.09%	Tradable Shares109.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"JIUYUAN GENE","latestPrice":8.33,"timestamp":1765526353893,"preClose":8,"halted":0,"volume":95600,"delay":0,"floatShares":109000000,"shares":245000000,"eps":0.7488148157194643,"marketStatus":"Market Closed","change":0.33,"latestTime":"12-12 15:59:13","open":8.18,"high":8.45,"low":8.18,"amount":798058,"amplitude":0.03375,"askPrice":8.4,"askSize":2000,"bidPrice":8.25,"bidSize":21000,"shortable":0,"etf":0,"ttmEps":0.6001320622617733,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":7,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":8,"dividendRate":0.007405,"openAndCloseTimeList":[[1765503000000,1765512000000],[1765515600000,1765526400000]],"volumeRatio":0.762603701096808,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02566","defaultTab":"news","newsList":[{"id":"1157354425","title":"JIUYUAN GENE (02566) Shareholder Deposits Shares with Huatai Hong Kong, Valued at HK$112 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1157354425","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157354425?lang=en_us&edition=fundamental","pubTime":"2025-12-05 08:28","pubTimestamp":1764894490,"startTime":"0","endTime":"0","summary":"Latest data from the Hong Kong Stock Exchange shows that on December 4, a shareholder of JIUYUAN GENE (02566) deposited shares with Huatai Hong Kong, with a deposit value of HK$112 million,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1116020942","title":"Jiuyuan Genetic (02566) Releases Monthly Return for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1116020942","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116020942?lang=en_us&edition=fundamental","pubTime":"2025-12-03 16:53","pubTimestamp":1764751991,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Stock Code: 02566) announced its monthly return report for the period ended 30 November 2025, confirming no changes in share capital or treasury...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"2588096775","title":"JiuYuan Genetic Sets Plan to List 136 Million Unlisted Shares in Hong Kong; Shares Rise 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588096775","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588096775?lang=en_us&edition=fundamental","pubTime":"2025-12-03 11:02","pubTimestamp":1764730977,"startTime":"0","endTime":"0","summary":"Hangzhou JiuYuan Genetic Biopharmaceutical (HKG:2566) said its board approved a proposal to convert 136.3 million domestic unlisted shares into H shares, according to a Tuesday Hong Kong bourse filing","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02566","BK1161"],"gpt_icon":0},{"id":"2588059178","title":"BRIEF-Hangzhou Jiuyuan Genetic Biopharmaceutical To Repurchase Up To 10.9 Million H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588059178","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588059178?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:21","pubTimestamp":1764685265,"startTime":"0","endTime":"0","summary":"BRIEF-Hangzhou Jiuyuan Genetic Biopharmaceutical To Repurchase Up To 10.9 Million H SharesDec 2  - Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd 2566.HK:TO REPURCHASE UP TO 10.9 MILLION H SHARES WITH ITS OWN FUNDS OF UP TO RMB100 MILLIONFurther company coverage: 2566.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nFWN3X801F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"gpt_icon":0},{"id":"2588032409","title":"Hangzhou Jiuyuan Gene Engineering Plans Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2588032409","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588032409?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:17","pubTimestamp":1764674239,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene Engineering  plans to repurchase up to over 10.9 million Hong Kong-listed shares for a  maximum of 100 million yuan, a Tuesday Hong Kong bourse filing said.The shares will be bought back from the open market from time to time during the period, according to the genetic engineering company.The repurchased shares may be cancelled, held as treasury shares, or used for the share incentive scheme.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1149215195","title":"Hangzhou Jiuyuan (2566) Announces Extraordinary General Meeting Details","url":"https://stock-news.laohu8.com/highlight/detail?id=1149215195","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149215195?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:04","pubTimestamp":1764673480,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Stock Code: 2566) has announced that an extraordinary general meeting will take place on December 22, 2025, at 2:00 p.m., in Conference Room 3,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"1139673335","title":"JIUYUAN GENE (02566) Proposes Appointment of Yan Weiting as Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1139673335","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139673335?lang=en_us&edition=fundamental","pubTime":"2025-12-02 18:56","pubTimestamp":1764672977,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) announced that Ms. Ma Honglan has submitted her resignation as a non-executive director due to reaching retirement age. Ms. Ma will cease to serve as a director of the company...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1173646450","title":"Jiuyuan Genetic (2566) Announces H Share Repurchase Plan Under Board-Approved Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=1173646450","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173646450?lang=en_us&edition=fundamental","pubTime":"2025-12-02 18:45","pubTimestamp":1764672303,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (2566) announced a plan to repurchase up to 10,909,678 H Shares in the open market. The share repurchase is funded with up to RMB100 million and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"1148878110","title":"JIUYUAN GENE (02566) Plans to Repurchase Shares with Up to RMB100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1148878110","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148878110?lang=en_us&edition=fundamental","pubTime":"2025-12-02 18:38","pubTimestamp":1764671894,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) announced that its board of directors resolved on December 2, 2025, to repurchase up to approximately 10.9097 million H shares in the open market using no more than RMB100...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"gpt_icon":0},{"id":"2588034594","title":"Hangzhou Jiuyuan Gene Engineering Announces Board Resignation and New Director Nomination","url":"https://stock-news.laohu8.com/highlight/detail?id=2588034594","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588034594?lang=en_us&edition=fundamental","pubTime":"2025-12-02 18:34","pubTimestamp":1764671699,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene Engineering Co. Ltd. announced the resignation of Ma Honglan as non-executive director due to retirement and proposed the appointment of a new non-executive director.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDLbhVx1R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"gpt_icon":0},{"id":"2588034595","title":"Hangzhou Jiuyuan Genetic Biopharmaceutical - to Repurchase up to 10.9 Mln H Shares With Its Own Funds of up to RMB100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2588034595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588034595?lang=en_us&edition=fundamental","pubTime":"2025-12-02 18:34","pubTimestamp":1764671679,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nFWN3X801F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02566","BK1161"],"gpt_icon":0},{"id":"2583527807","title":"Chinese doctors call for insurance coverage for weight-loss drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2583527807","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583527807?lang=en_us&edition=fundamental","pubTime":"2025-11-14 15:14","pubTimestamp":1763104497,"startTime":"0","endTime":"0","summary":"Chinese doctors call for insurance coverage for weight-loss drugsObesity China's sixth leading risk factor in disability, deathNumber of overweight, obese to increase to 65% by 2030Weight-loss drugs too expensive, doctors sayGenerics could bring price pressure, Goldman Sachs analysts sayBy Andrew Silver","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nL6N3WN0C0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","LU2097828805.USD","BK0175","LU2242644610.SGD","SG9999004220.SGD","LU1993786604.SGD","IE00B031HY20.USD","BK0187","LU0072913022.USD","LU2097828714.EUR","LU1951186391.HKD","000963","NHC","LU0315179316.USD","LU1226287792.SGD","BK1515","LU1226287875.USD","02566","BK1161","LU1226288170.HKD","LU1226287529.USD","BK1589","LU1813983027.USD","01801","LU1152091754.HKD","LU1328277881.USD","LU1969619763.USD","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2097828474.EUR","LU2039709279.SGD","BK1521","IE00BZ08YR35.GBP","LU2097828631.EUR","LU1960683339.HKD","BK1583","LU1152091168.USD","HK0000165453.HKD","BK0132","IE0008368742.USD","LU0326950275.SGD","LU0501845795.SGD","LU1807302812.USD","LU2097828557.USD","BK0209","01093","IE0008369823.USD","LU0067412154.USD","BK1191"],"gpt_icon":0},{"id":"1128125179","title":"JIUYUAN GENE (02566) Shareholder Deposits Shares with Huatai Hong Kong, Valued at HK$97.89 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1128125179","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128125179?lang=en_us&edition=fundamental","pubTime":"2025-11-13 08:20","pubTimestamp":1762993217,"startTime":"0","endTime":"0","summary":"Latest data from the Hong Kong Stock Exchange reveals that on November 12, a shareholder of JIUYUAN GENE (02566) deposited shares with Huatai Hong Kong, with a market value of HK$97.89 million,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1119511358","title":"Hangzhou Jiuyuan Genetic Biopharmaceutical (02566) Releases Monthly Return with No Changes in Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1119511358","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119511358?lang=en_us&edition=fundamental","pubTime":"2025-11-05 16:47","pubTimestamp":1762332447,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical (02566) published its monthly return for the period ended 31 October 2025. The registered share capital remained at RMB 245,398,800, comprising 109,096,785...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"1108974481","title":"Stock Track | JIUYUAN GENE Soars 5.63% Despite Mixed Interim Results, Boosted by Strong Orthopedic Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1108974481","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108974481?lang=en_us&edition=fundamental","pubTime":"2025-08-20 15:40","pubTimestamp":1755675651,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) experienced a significant surge in its stock price during Wednesday's intraday trading, with shares soaring 5.63%. This upward movement comes on the heels of the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02566"],"gpt_icon":0},{"id":"1147895737","title":"Stock Track | JIUYUAN GENE Soars 5.63% Following Earnings Release: Orthopedic Sales Shine Despite Overall Revenue Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=1147895737","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147895737?lang=en_us&edition=fundamental","pubTime":"2025-08-20 15:40","pubTimestamp":1755675644,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) saw its stock soar 5.63% in intraday trading on Wednesday, following the release of its interim results for the first half of 2025. The biotech company's shares climbed despite...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02566"],"gpt_icon":0},{"id":"1142508442","title":"Hong Kong Stocks Move | JIUYUAN GENE (02566) Surges Over 7% Post-Earnings with Interim Net Profit of RMB 90.174 Million, Orthopedic Product Sales Up Over 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142508442","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142508442?lang=en_us&edition=fundamental","pubTime":"2025-08-20 10:50","pubTimestamp":1755658224,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) surged over 7% following its earnings release. As of press time, the stock was up 7.02% to HK$15.4, with turnover reaching HK$10.2428 million. On August 19, JIUYUAN GENE...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"gpt_icon":0},{"id":"2560594841","title":"Hangzhou Jiuyuan Gene Engineering's H1 Profit Shrinks; Shares Fall 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560594841","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560594841?lang=en_us&edition=fundamental","pubTime":"2025-08-19 11:48","pubTimestamp":1755575300,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene Engineering  reported 90.2 million yuan in attributable profit for the half ended June 30, falling from 105.3 million yuan a year earlier, according to a Hong Kong bourse filing Monday.Earnings per share were 0.37 yuan, compared with 0.53 yuan in the prior year.Revenue fell 9% year-on-year to 638.8 million yuan, figures showed.Shares of the company declined over 4% in late-morning trade Tuesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1123355272","title":"From Accumulation and Washout to Second Rally: JIUYUAN GENE (02566) Capital Operations and the Billion-Dollar Potential of Semaglutide","url":"https://stock-news.laohu8.com/highlight/detail?id=1123355272","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123355272?lang=en_us&edition=fundamental","pubTime":"2025-08-19 10:59","pubTimestamp":1755572383,"startTime":"0","endTime":"0","summary":"On August 18, Hong Kong's biotech sector witnessed a \"secondary market\" phenomenon as JIUYUAN GENE (02566) touched an intraday high of HK$16.29, representing a surge of over 218% from its low of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"gpt_icon":0},{"id":"1133400676","title":"Hong Kong Stock Movement | JIUYUAN GENE (02566) Surges Nearly 24% in Late Trading, Set to Release Results Next Monday, Expected to Submit Semaglutide New Drug Applications to Brazil and Other Countries This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1133400676","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133400676?lang=en_us&edition=fundamental","pubTime":"2025-08-15 15:50","pubTimestamp":1755244251,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) surged nearly 24% in late trading. As of press time, the stock was up 23.72% to HK$15.28, with a trading volume of HK$41.215 million. On the news front, JIUYUAN GENE plans to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-gene.com","stockEarnings":[{"period":"1week","weight":-0.0012},{"period":"1month","weight":0.079},{"period":"3month","weight":-0.3482},{"period":"6month","weight":-0.167},{"period":"1year","weight":0.1141},{"period":"ytd","weight":0.2692}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0872},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.295}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd, formerly Hangzhou Jiuyuan Gene Engineering Co Ltd, is a China-based company principally engaged in the research, development, manufacturing and commercialization of biopharmaceutical products and medical devices. The Company focuses on orthopedics, metabolic diseases, oncology and blood treatment. The Company's orthopedic products include Guyoudao bone repair materials. The Company's oncology products include Jilifen, Jijufen, Jiouting, Jifuwei, and Jitansu. The Company's blood products include Jipailin and Yinuojia. The Company's products are mainly used to treat diseases such as diabetes, multiple myeloma, thrombocytopenia, and neutropenia. The Company mainly operates its businesses in the domestic and overseas markets.","exchange":"SEHK","name":"JIUYUAN GENE","nameEN":"JIUYUAN GENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"JIUYUAN GENE(02566),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest JIUYUAN GENE(02566) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"JIUYUAN GENE,02566,JIUYUAN GENE股票,JIUYUAN GENE股票老虎,JIUYUAN GENE股票老虎国际,JIUYUAN GENE行情,JIUYUAN GENE股票行情,JIUYUAN GENE股价,JIUYUAN GENE股市,JIUYUAN GENE股票价格,JIUYUAN GENE股票交易,JIUYUAN GENE股票购买,JIUYUAN GENE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"JIUYUAN GENE(02566),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest JIUYUAN GENE(02566) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}